AUL
GILD icon

AlphaGrep UK Ltd’s Gilead Sciences GILD Stock Holding History

AlphaGrep UK Ltd’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$621K Buy
4,455
+449
+11% +$62.9K 0.18% 147
2025
Q4 		$492K Buy
+4,006
New +$487K 0.16% 211

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AlphaGrep UK Ltd's GILD Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Gilead Sciences (GILD) stake by 11% in Q1 2026, buying an estimated $62.9K and bringing the position to 4,455 shares worth $621K. The position accounts for 0.18% of the portfolio, ranked #147.

AlphaGrep UK Ltd first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,318 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AlphaGrep UK Ltd held 4,455 shares of Gilead Sciences worth $621K as of Q1 2026.
  • AlphaGrep UK Ltd bought 449 Gilead Sciences shares in Q1 2026, an estimated $62.9K.
  • Gilead Sciences made up 0.18% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #147 holding.
  • AlphaGrep UK Ltd first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,318 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.